Filing Details
- Accession Number:
- 0001415889-22-007017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-28 16:10:15
- Reporting Period:
- 2022-06-24
- Accepted Time:
- 2022-06-28 16:10:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1477449 | Teladoc Health Inc. | TDOC | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 043705970 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1780955 | Mala Murthy | C/O Teladoc Health, Inc. 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-06-24 | 7,968 | $0.00 | 31,348 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-06-27 | 4,053 | $37.32 | 27,295 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2022-06-24 | 7,968 | $0.00 | 7,968 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct |
Footnotes
- Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.
- On June 24, 2019, the reporting person was granted 31,872 restricted stock units, vesting as to 25% of the shares on February 20, 2020 with the remainder of the shares vesting in three equal annual installments beginning on the first anniversary of the grant date.